Invention Grant
- Patent Title: Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
-
Application No.: US16085536Application Date: 2017-03-16
-
Publication No.: US10759806B2Publication Date: 2020-09-01
- Inventor: Catherine A. Evans
- Applicant: Infinity Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Infinity Pharmaceuticals, Inc.
- Current Assignee: Infinity Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Jones Day
- International Application: PCT/US2017/022705 WO 20170316
- International Announcement: WO2017/161116 WO 20170921
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D487/04 ; A61P37/00 ; A61P35/00
Abstract:
Provided are isotopologues of isoquinolinone and quinazolinone compounds of formula (AB′) that modulate PI3 kinase activity, processes for the preparation of the compounds, pharmaceutical compositions comprising the compounds, and methods of treatment of diseases and disorders using the compounds or pharmaceutical compositions.
Public/Granted literature
- US20190202835A1 ISOTOPOLOGUES OF ISOQUINOLINONE AND QUINAZOLINONE COMPOUNDS AND USES THEREOF AS PI3K KINASE INHIBITORS Public/Granted day:2019-07-04
Information query
IPC分类:
